FDA Inspection
Chongqing Biocare Pharmaceutical Ltd.Chongqing Biocare Pharmaceutical Ltd. – FDA Inspection, Sep 22, 2023
Record Details
This FDA Inspection record concerns Chongqing Biocare Pharmaceutical Ltd., with an inspection on September 22, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bf1dc6a0-12a8-4a1e-8a3a-9a39bc6fc3f1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1219461
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chongqing Biocare Pharmaceutical Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Biocare Pharmaceutical Ltd.
- FDA Inspection 970979 - 2016-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.